Showing results (251-260 of 11,696) with videos related to
Sort By:
Pageof 1,170
European Heart Journal|September 27, 2007
Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart StudyNisha I Parikh, Philimon Gona, Martin G Larson, et al.European Heart Journal|December 1, 1991
Intravenous nitroglycerin suppresses exercise-induced arrhythmias in patients with ischaemic heart disease: implications for long-term treatmentA Margonato, F Bonetti, A Mailhac, et al.European Heart Journal|December 1, 1991
The comparative value of exercise echocardiography and 99m Tc MIBI single photon emission computed tomography in the diagnosis and localization of myocardial ischaemiaM M Pozzoli, A Salustri, G R Sutherland, et al.European Heart Journal|December 1, 1991
Successful catheter ablation by radiofrequency energy of posteroseptal accessory pathway in a patient with drug refractory Wolff-Parkinson-White syndromeP Delise, A Bonso, A Raviele, et al.European Heart Journal|July 31, 2008
Discontinuation of statin therapy following an acute myocardial infarction: a population-based studyStella S Daskalopoulou, Joseph A C Delaney, Kristian B Filion, et al.European Heart Journal|March 27, 2012
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trialsGiulio G Stefanini, Robert A Byrne, Patrick W Serruys, et al.European Heart Journal|February 15, 2022
Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational studyYufei Chen, Wanrong Fu, Yunbo Zheng, et al.European Heart Journal|February 1, 1986
A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenonD O Corbin, D A Wood, C C Macintyre, et al.European Heart Journal|September 27, 2021
Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanismsXiu Liu, Jia-Wei Guo, Xiao-Chun Lin, et al.European Heart Journal|October 7, 2021
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II studyAdrian P Banning, Patrick Serruys, Giovanni Luigi De Maria, et al.Pageof 1,170